India  

Covishield is `safe and immunogenic`, has no side effects, asserts Serum Institute of India

Zee News Tuesday, 1 December 2020
The vaccine candidate, Covishield, is being developed by the UK's Oxford University and US pharma giant AstraZeneca. The SII is a manufacturing partner for the vaccine.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

'40-50 million doses of Covishield stockpiled': Serum Institute of India [Video]

'40-50 million doses of Covishield stockpiled': Serum Institute of India

Briefing about the status of coronavirus vaccine, Serum Institute of India CEO Adar Poonawalla informed that 40-50 million doses of Covishield have been stockpiled. "We have 40-50 million doses of..

Credit: ANI     Duration: 01:43Published
Bharat Bandh: Protesting farmers block the Delhi-Meerut highway|Oneindia News [Video]

Bharat Bandh: Protesting farmers block the Delhi-Meerut highway|Oneindia News

Protesting farmers on Tuesday completely blocked Delhi-Meerut expressway at Ghazipur-Ghaziabad border that connects Delhi and Ghaziabad amid their call for Bharat Bandh. The ruling Aam Aadmi Party in..

Credit: Oneindia     Duration: 02:40Published
Serum Institute of India seeks approval for its Covid vaccine Covidshield | Oneinda News [Video]

Serum Institute of India seeks approval for its Covid vaccine Covidshield | Oneinda News

After American firm Pfizer sought approval from the drug regulator, Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency..

Credit: Oneindia     Duration: 01:22Published

Related news from verified sources

Coronavirus: amid vaccine volunteer’s allegations, Serum Institute of India stresses safety of ‘Covishield’

Last week, a 40-year-old vaccine volunteer alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions.
Hindu

Serum says AstraZeneca's Covid-19 vaccine safe, no co-relation with side-effects

Serum Institute of India, the world's largest vaccine manufacturer, on Tuesday denied allegations that a Covid-19 trial volunteer suffered serious side effects...
IndiaTimes